Perforomist Related Published Studies
Well-designed clinical trials related to Perforomist (Formoterol Inhalation)
Safety and Tolerability of High-Dose Budesonide/Formoterol via Turbuhaler(R) in Japanese Patients with Asthma: A Randomized, Double-Blind, Crossover, Active Comparator-Controlled, Phase III Study. [2012.01.01]
Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial. [2011.09]
Bronchodilator responsiveness and onset of effect with budesonide/formoterol pMDI in COPD. [2011.08]
Budesonide/formoterol maintenance and reliever therapy versus conventional best standard treatment in asthma in an attempted 'real life' setting. [2011.07]
Effects of formoterol and tiotropium bromide on mucus clearance in patients with COPD. [2011.06]
Efficacy and safety of fluticasone and formoterol in a single pressurized metered dose inhaler. [2011.05]
Rapid onset of bronchodilation with formoterol/beclomethasone Modulite and formoterol/budesonide Turbuhaler as compared to formoterol alone in patients with COPD. [2011.02]
Combined treatment with formoterol and tiotropium is more efficacious than treatment with tiotropium alone in patients with chronic obstructive pulmonary disease, regardless of smoking status, inhaled corticosteroid use, baseline severity, or gender. [2011.02]
Sodium cromoglycate and eformoterol attenuate sensitivity and reactivity to inhaled mannitol in subjects with bronchiectasis. [2011.01]
Long-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthma. [2010.12]
Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD. [2010.10]
Effectiveness and safety of adjustable maintenance dosing with budesonide/formoterol turbuhaler compared with traditional fixed doses in bronchial asthma: a multi-centre Nigerian study. [2010.09]
Comparison of two twice-daily doses of budesonide/formoterol maintenance and reliever therapy. [2010.09]
Economic evaluation of BDP/formoterol fixed vs two single inhalers in asthma treatment. [2010.09]
Effects of extra-fine inhaled beclomethasone/formoterol on both large and small airways in asthma. [2010.07]
Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study. [2010.05.28]
Formoterol for acute asthma in the emergency department: a systematic review with meta-analysis. [2010.03]
The safety and efficacy of arformoterol and formoterol in COPD. [2010.02]
Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma. [2010.02]
Efficacy and safety of budesonide/formoterol pressurized metered-dose inhaler: randomized controlled trial comparing once- and twice-daily dosing in patients with asthma. [2010.01]
The functionality of a budesonide/formoterol pressurized metered-dose inhaler with an integrated actuation counter. [2010.01]
Fixed or adjustable maintenance-dose budesonide/formoterol compared with fixed maintenance-dose salmeterol/fluticasone propionate in asthma patients aged >or=16 years: post hoc analysis of a randomized, double-blind/open-label extension, parallel-group study. [2010]
Comparative bioavailability of two hydrofluoroalkane formulations of formoterol fumarate both delivered by pressurised metered dose inhaler. [2010]
Treatment comparison of budesonide/formoterol with salmeterol/fluticasone propionate in adults aged > or =16 years with asthma: post hoc analysis of a randomized, double-blind study. [2010]
Impact of tiotropium on the course of moderate-to-very severe chronic obstructive
pulmonary disease: the UPLIFT trial. [2010]
The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial. [2009.10.31]
Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. [2009.10.15]
A comparison of budesonide/formoterol maintenance and reliever therapy vs. conventional best practice in asthma management. [2009.10]
[Prospective evaluation of the efficacy of the combination of budesonide/formoterol in obstructive airway disease after allogeneic hematopoietic stem cell transplantation] [2009.09]
A randomized, comparative study of formoterol and terbutaline dry powder inhalers in the treatment of mild to moderate asthma exacerbations in the pediatric acute care setting. [2009.09]
Comparison of the efficacy and safety of arformoterol 15 microg twice daily and arformoterol 30 microg once daily in COPD: a single-dose, multicenter, randomized, modified-blind, two-way crossover study. [2009.08]
Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD. [2009.08]
Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial. [2009.06.18]
Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol. [2009.05]
Effect of formoterol with or without budesonide in repeated low-dose allergen challenge. [2009.04]
Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD. [2009.04]
Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD. A double-blind, randomised, non-inferiority, parallel-group, multicentre study. [2009.02.19]
Lung function and asthma control with beclomethasone and formoterol in a single inhaler. [2009.01]
Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial. [2009]
Systemic exposure and implications for lung deposition with an extra-fine hydrofluoroalkane beclometasone dipropionate/formoterol fixed combination. [2009]
Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler. [2008.11]
Arrhythmias in patients with chronic obstructive pulmonary disease (COPD): occurrence frequency and the effect of treatment with the inhaled long-acting beta2-agonists arformoterol and salmeterol. [2008.11]
Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study. [2008.11]
Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations. [2008.10]
Inflammatory and functional effects of increasing asthma treatment with formoterol or double dose budesonide. [2008.10]
Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids. [2008.09]
Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients. [2008.09]
Equivalence of a single saline nebulised dose of formoterol powder vs three doses of nebulised Albuterol every twenty minutes in acute asthma in children: a suitable cost effective approach for developing nations. [2008.07]
Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients. [2008.06]
[Immediate bronchodilator response to formoterol in poorly reversible chronic obstructive pulmonary disease] [2008.06]
Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids. [2008.05]
Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: A placebo-controlled trial. [2008.04]
Efficacy of formoterol Turbuhaler in the emergency treatment of patients with obstructive airway diseases. [2008.04]
Bronchodilation of formoterol administered with budesonide: Device and formulation effects. [2008.03]
Long duration of airway but not systemic effects of inhaled formoterol in asthmatic patients. [2008.03]
Formoterol fumarate inhalation powder vs albuterol nebulizer for the treatment of asthma in the acute care setting. [2008.02]
Effect of nebulized arformoterol on airway function in COPD: results from two randomized trials. [2008.02]
Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help? [2008.01]
Efficacy and safety of formoterol delivered through the Novolizer, a novel dry powder inhaler (DPI) compared with a standard DPI in patients with moderate to severe asthma. [2008]
Tolerability of high cumulative doses of the HFA modulite beclomethasone dipropionate/formoterol combination inhaler in asthmatic patients. [2008]
Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. [2007.12]
Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma. [2007.11]
Cardiac safety profile of nebulized formoterol in adults with COPD: a 12-week, multicenter, randomized, double- blind, double-dummy, placebo- and active-controlled trial. [2007.10]
Effects of formoterol on exercise tolerance in severely disabled patients with COPD. [2007.10]
Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction. [2007.09]
Lung deposition and efficacy of inhaled formoterol in patients with moderate to severe COPD. [2007.09]
Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life. [2007.07.04]
A randomised, double-blind, placebo-controlled study to evaluate the role of formoterol in the management of acute asthma. [2007.05]
Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. [2007.05]
Formoterol turbuhaler is as effective as salbutamol diskus in relieving adenosine-induced bronchoconstriction in children. [2007.03]
Randomised trial comparing as-needed versus regular treatment with formoterol in patients with persistent asthma. [2007.03]
Nebulized arformoterol in patients with COPD: A 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial. [2007.02]
The effects of inhaled budesonide and formoterol in combination and alone when given directly after allergen challenge. [2007.02]
Cardiac safety of formoterol 12mug twice daily in patients with chronic obstructive pulmonary disease. [2007]
Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study. [2006.12.04]
The effect of formoterol inhalation on endurance performance in hypobaric conditions. [2006.12]
Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma. [2006.12]
Effect of formoterol fumarate treatment on exercise-induced bronchoconstriction in children. [2006.09]
Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. [2006.08.26]
EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma. [2006.07]
Comparison of the acute effect of tiotropium versus a combination therapy with single inhaler budesonide/formoterol on the degree of resting pulmonary hyperinflation. [2006.07]
Efficacy of inhaled formoterol in reversing bronchoconstriction. [2006.05]
Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study. [2006.05]
Acute relief of exercise-induced bronchoconstriction by inhaled formoterol in children with persistent asthma. [2006.05]
Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma. [2006.05]
Inhaled formoterol versus ipratropium bromide in chronic obstructive pulmonary disease. [2006.04]
Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. [2006.02]
Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol. [2006.01.24]
Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial. [2006]
Is there any difference between effects of ipratropium bromide and formoterol on exercise capacity in moderate COPD patients? [2006]
Onset and duration of action of formoterol and tiotropium in patients with moderate to severe COPD. [2006]
Clinically equivalent bronchodilatation achieved with formoterol delivered via Easyhaler and Aerolizer. [2006]
Well-designed clinical trials possibly related to Perforomist (Formoterol Inhalation)
Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial. [2011.09.10]
Comparing asthma treatment in elderly versus younger patients. [2011.06]
Application of latent growth and growth mixture modeling to identify and
characterize differential responders to treatment for COPD. [2011]
A randomized, open labeled, comparative study to assess the efficacy and safety of controller medications as add on to inhaled corticosteroid and long-acting beta2 agonist in the treatment of moderate-to-severe persistent asthma. [2010.10]
Long-acting beta-agonists with and without inhaled corticosteroids and catastrophic asthma events. [2010.04]
Single maintenance and reliever therapy (SMART) of asthma: a critical appraisal. [2010]
Can patients with asthma feel inhaler therapy working right away? Two clinical trials testing the effect of timing of assessment on patient perception. [2009.12]
[Effect of transfer factor on treatment with glucocorticoids in a group of pediatric patients with persistent moderate allergic asthma] [2009.05]
Efficacy and safety of once or twice daily inhalation of extrafine HFA beclomethasone dipropionate in patients with mild to moderate asthma. [2007.11]
|
